3i Nanotech develops point-of-care platform technology to track protein biomarkers in human samples.
3i Nanotech develops point-of-care platform technology to track protein biomarkers in human samples. The company was founded in 2018 and is based in Greensboro, North Carolina.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 24, 2019 | Grant | $224.49K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |